Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

INDUSTRY 6 OTHER 2 NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1 COVID-19 1

Interventions

Radiotherapy 299 Cisplatin 263 Cyclophosphamide 229 Doxorubicin 176 Paclitaxel 167 Vincristine 160 Carboplatin 150 Filgrastim 139 Etoposide 139 Gemcitabine 118 Fluorouracil 113 Docetaxel 112 Methotrexate 106 Dexamethasone 106 Cytarabine 106 Prednisone 91 Leucovorin 90 Granulocyte Colony-Stimulating Factor 74 Specimen Handling 66 Magnetic Resonance Spectroscopy 62 Capecitabine 59 Irinotecan 58 Radiation 54 Ifosfamide 51 Oxaliplatin 48 Daunorubicin 48 Temozolomide 47 Radiotherapy, Conformal 47 Platinum 47 Peripheral Blood Stem Cell Transplantation 47

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Interventional × IMM-101 × Clear all

NCT04442048 2025-12-30

COV-IMMUNO

Canadian Cancer Trials Group

Phase 3 Completed

COVID-19, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡